Other inflammatory markers showed no significant causal relationship with this condition.<h4>Conclusion</h4>This study identifies MIP1β, IL-10, and IL-12p70 as potential therapeutic targets for preventing or treating postherpetic neuralgia, underscoring the need for further research in this area. This evidence concerns the gene CCL4 and postherpetic neuralgia.